Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
Go back to Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting| (NASDAQ: IMUX) | Delayed: 7.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.48 | 52 Week High | $ | |||
| Open | $7.48 | 52 Week Low | $ | |||
| Day High | $7.48 | P/E | N/A | |||
| Day Low | $7.48 | EPS | $ | |||
| Volume | 88 | |||||



